These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 31698055)

  • 1. Heterogeneity of dopamine release sites in health and degeneration.
    Lebowitz JJ; Khoshbouei H
    Neurobiol Dis; 2020 Feb; 134():104633. PubMed ID: 31698055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role for VGLUT2 in selective vulnerability of midbrain dopamine neurons.
    Steinkellner T; Zell V; Farino ZJ; Sonders MS; Villeneuve M; Freyberg RJ; Przedborski S; Lu W; Freyberg Z; Hnasko TS
    J Clin Invest; 2018 Feb; 128(2):774-788. PubMed ID: 29337309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-related accumulation of Marinesco bodies and lipofuscin in rhesus monkey midbrain dopamine neurons: relevance to selective neuronal vulnerability.
    Kanaan NM; Kordower JH; Collier TJ
    J Comp Neurol; 2007 Jun; 502(5):683-700. PubMed ID: 17436290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synaptic transmission in the striatum: from plasticity to neurodegeneration.
    Calabresi P; Centonze D; Gubellini P; Marfia GA; Pisani A; Sancesario G; Bernardi G
    Prog Neurobiol; 2000 Jun; 61(3):231-65. PubMed ID: 10727775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatodendritic dopamine release: recent mechanistic insights.
    Rice ME; Patel JC
    Philos Trans R Soc Lond B Biol Sci; 2015 Jul; 370(1672):. PubMed ID: 26009764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.
    Cummings JL; Henchcliffe C; Schaier S; Simuni T; Waxman A; Kemp P
    Brain; 2011 Nov; 134(Pt 11):3146-66. PubMed ID: 21810889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NAD
    Lautrup S; Sinclair DA; Mattson MP; Fang EF
    Cell Metab; 2019 Oct; 30(4):630-655. PubMed ID: 31577933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of dopamine quantal size in midbrain and hippocampal neurons.
    Pothos EN
    Behav Brain Res; 2002 Mar; 130(1-2):203-7. PubMed ID: 11864736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse relationship between the contents of neuromelanin pigment and the vesicular monoamine transporter-2: human midbrain dopamine neurons.
    Liang CL; Nelson O; Yazdani U; Pasbakhsh P; German DC
    J Comp Neurol; 2004 May; 473(1):97-106. PubMed ID: 15067721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-dependent nigral dopaminergic neurodegeneration and α-synuclein accumulation in RGS6-deficient mice.
    Luo Z; Ahlers-Dannen KE; Spicer MM; Yang J; Alberico S; Stevens HE; Narayanan NS; Fisher RA
    JCI Insight; 2019 May; 5(13):. PubMed ID: 31120439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective cell death in neurodegeneration: why are some neurons spared in vulnerable regions?
    Double KL; Reyes S; Werry EL; Halliday GM
    Prog Neurobiol; 2010 Nov; 92(3):316-29. PubMed ID: 20541584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta.
    Freestone PS; Guatteo E; Piscitelli F; di Marzo V; Lipski J; Mercuri NB
    Neuropharmacology; 2014 Apr; 79():467-75. PubMed ID: 24334069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease as a result of aging.
    Rodriguez M; Rodriguez-Sabate C; Morales I; Sanchez A; Sabate M
    Aging Cell; 2015 Jun; 14(3):293-308. PubMed ID: 25677794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interactions of iron, dopamine and neuromelanin pathways in brain aging and Parkinson's disease.
    Zucca FA; Segura-Aguilar J; Ferrari E; Muñoz P; Paris I; Sulzer D; Sarna T; Casella L; Zecca L
    Prog Neurobiol; 2017 Aug; 155():96-119. PubMed ID: 26455458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic modulation of synaptic transmission in cortex and striatum.
    Tritsch NX; Sabatini BL
    Neuron; 2012 Oct; 76(1):33-50. PubMed ID: 23040805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Environment- and activity-dependent dopamine neurotransmitter plasticity in the adult substantia nigra.
    Aumann TD
    J Chem Neuroanat; 2016 Apr; 73():21-32. PubMed ID: 26718607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine midbrain neurons in health and Parkinson's disease: emerging roles of voltage-gated calcium channels and ATP-sensitive potassium channels.
    Dragicevic E; Schiemann J; Liss B
    Neuroscience; 2015 Jan; 284():798-814. PubMed ID: 25450964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine selectively blocks inhibitory glutamate transmission in dopamine neurons.
    Paladini CA; Fiorillo CD; Morikawa H; Williams JT
    Nat Neurosci; 2001 Mar; 4(3):275-81. PubMed ID: 11224544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The nature of catecholamine-containing neurons in the enteric nervous system in relationship with organogenesis, normal human anatomy and neurodegeneration.
    Natale G; Ryskalin L; Busceti CL; Biagioni F; Fornai F
    Arch Ital Biol; 2017 Sep; 155(3):118-130. PubMed ID: 29220864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia.
    Galter D; Buervenich S; Carmine A; Anvret M; Olson L
    Neurobiol Dis; 2003 Dec; 14(3):637-47. PubMed ID: 14678778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.